Budget Amount *help |
¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
We study fatty acid synthase (FASN) and carnitine palmitoyltransferase 1C(CPT1C) related to fatty acid metabolism in human gliomas.We performed an expression of mRNA by using Real-time PCR.In human glioma cell lines, Both mRNA of FASN and CPT1C increased in glucose-free medium. Metformine is known a drug with effect of anticancer agent.In the medium administrated to metformine,mRNA of CPT1C increased in the human glioma cell lines.
|